CC
REGN icon

ClearArc Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

ClearArc Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$280K Sell
745
-345
-32% -$116K 0.11% 221
2019
Q3 		$302K Buy
1,090
+23
+2% +$6.81K 0.09% 262
2019
Q2 		$334K Sell
1,067
-123
-10% -$40.9K 0.1% 238
2019
Q1 		$489K Sell
1,190
-142
-11% -$58.5K 0.13% 184
2018
Q4 		$498K Sell
1,332
-653
-33% -$239K 0.15% 167
2018
Q3 		$802K Sell
1,985
-6
-0.3% -$2.28K 0.11% 192
2018
Q2 		$687K Buy
1,991
+16
+0.8% +$5K 0.1% 207
2018
Q1 		$680K Buy
1,975
+14
+0.7% +$4.87K 0.1% 208
2017
Q4 		$737K Sell
1,961
-18
-0.9% -$7.29K 0.1% 203
2017
Q3 		$885K Buy
1,979
+91
+5% +$43.3K 0.13% 166
2017
Q2 		$927K Buy
1,888
+38
+2% +$16.6K 0.15% 156
2017
Q1 		$717K Buy
1,850
+5
+0.3% +$1.85K 0.12% 185
2016
Q4 		$677K Sell
1,845
-19
-1% -$7.22K 0.12% 183
2016
Q3 		$749K Sell
1,864
-18
-1% -$7.22K 0.14% 168
2016
Q2 		$657K Sell
1,882
-27
-1% -$10.4K 0.13% 179
2016
Q1 		$688K Buy
1,909
+26
+1% +$10.7K 0.15% 168
2015
Q4 		$1.02M Buy
1,883
+8
+0.4% +$4.33K 0.21% 127
2015
Q3 		$872K Buy
1,875
+8
+0.4% +$4.3K 0.18% 155
2015
Q2 		$952K Buy
1,867
+262
+16% +$128K 0.17% 160
2015
Q1 		$725K Buy
1,605
+8
+0.5% +$3.39K 0.15% 180
2014
Q4 		$655K Buy
1,597
+84
+6% +$33K 0.13% 191
2014
Q3 		$545K Sell
1,513
-96
-6% -$32.2K 0.12% 201
2014
Q2 		$454K Buy
1,609
+54
+3% +$16K 0.1% 224
2014
Q1 		$467K Sell
1,555
-87
-5% -$26.8K 0.12% 216
2013
Q4 		$452K Buy
1,642
+45
+3% +$12.9K 0.12% 207
2013
Q3 		$500K Sell
1,597
-712
-31% -$187K 0.14% 183
2013
Q2 		$519K Buy
+2,309
New +$538K 0.14% 180

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

ClearArc Capital's REGN Position: Q4 2019 in Review

ClearArc Capital reduced its Regeneron Pharmaceuticals (REGN) stake by 32% in Q4 2019, selling an estimated $116K and leaving 745 shares worth $280K. The position accounts for 0.11% of the portfolio, ranked #221.

ClearArc Capital first reported a position in REGN in Q2 2013 and has held it in 27 quarters since. The position peaked at $1.02M in Q4 2015. 703 funds tracked by Wall St. Rank hold REGN as of Q4 2019.

  • ClearArc Capital held 745 shares of Regeneron Pharmaceuticals worth $280K as of Q4 2019.
  • ClearArc Capital sold 345 Regeneron Pharmaceuticals shares in Q4 2019, an estimated $116K.
  • Regeneron Pharmaceuticals made up 0.11% of ClearArc Capital's portfolio in Q4 2019, its #221 holding.
  • ClearArc Capital first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 27 quarters since.
  • ClearArc Capital's Regeneron Pharmaceuticals position peaked at $1.02M in Q4 2015.
  • 703 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2019.

Based on ClearArc Capital's 13F filing for Q4 2019, filed 14 Feb 2020.